Nitisinone is widely used to treat children with hereditary tyrosinemia type 1 (HT-1), a rare genetic condition. Paediatric patients of all ages are given it, from infancy to puberty. The Nitisinone dosage may vary depending on the patient's response and general health. Blood and urine parameters must be periodically checked to confirm the medication's effectiveness and safety. A low-protein diet with decreased tyrosine and phenylalanine intake is frequently suggested in addition to Nitisinone therapy. Healthcare practitioners with experience treating HT-1 should closely monitor the administration of Nitisinone to children to improve patient outcomes.
For more information on the drug and nitisinone cost, contact The Indian Pharma. To know more, visit https://theindianpharma.com/nitisinone/.
